Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
June 05 2009 - 6:30AM
PR Newswire (US)
SEATTLE, June 5 /PRNewswire-FirstCall/ -- Dendreon Corporation
(NASDAQ: DNDN) today announced that management will present at the
following two investor conferences next week. Goldman Sachs 30th
Annual Global Healthcare Conference Tuesday, June 9, 2009 4:20 p.m.
ET 8th Annual Needham Life Sciences Conference Thursday, June 11,
2009 11:00 a.m. ET The presentations will be audio webcast live and
available for replay from Dendreon's website,
http://www.dendreon.com/. Dendreon Corporation is a biotechnology
company whose mission is to target cancer and transform lives
through the discovery, development and commercialization of novel
therapeutics. The Company applies its expertise in antigen
identification, engineering and cell processing to produce active
cellular immunotherapy product candidates designed to stimulate an
immune response. Dendreon is also developing an orally-available
small molecule that targets TRPM8 that could be applicable to
multiple types of cancer as well as benign prostatic hyperplasia.
The Company has its headquarters in Seattle, Washington and is
traded on the Nasdaq Global Market under the symbol DNDN. For more
information about the Company and its programs, visit
http://www.dendreon.com/. DATASOURCE: Dendreon Corporation CONTACT:
Jennifer Williams, Investor Relations of Dendreon Corporation,
+1-206-829-1500 Web Site: http://www.dendreon.com/
Copyright